Press "Enter" to skip to content

Raleigh drug firm lands FDA approval for treatment of intestinal infection affecting millions

Raleigh drug firm lands FDA approval for treatment of intestinal infection affecting millionsRedHill Biopharma has received FDA approval for a treatment of a potentially deadly intestinal disease that affects 2 million people annually in the US and millions more worldwide.
Source: WRAL News

Be First to Comment

    Leave a Reply